Notes / Company

Indegene Ltd.

INDGN BSE 544172 ISIN INE065X01017 Pharmaceuticals

Fundamentals

Market cap: ₹12,480 cr
P/E: 31.11×
ROE: 15.55%
Debt / equity: 0.00
Div yield: 0.43%
52-week range: 414.00 — 596.80

The timeline — 1 note on Indegene Ltd.

July 2026

10 Jul 26 · 2:50 PM IST Brief

Brief · Mid cap

Indegene board to meet July 30 for Q1 results, ESOP allotment

A routine quarterly board meeting to approve unaudited results and allot shares under existing employee stock schemes. No strategic or financial surprises expected.

Verify on exchange BSE filings for INDGN NSE filings for INDGN